加紧扩大规模
Tempus AI Launches AI Powered Prostate Cancer Risk Test<blockquote>腾邦AI推出AI驱动的前列腺癌风险测试</blockquote>
Tempus AI has launched a new prostate test for metastatic hormone-sensitive prostate cancer patients, the company said Thursday.The ArteraAI prostate test uses artificial intelligence to assess a patient's clinical data and biopsy images to estimate a patient's likelihood of prostate cancer-specific mortality, Tempus AI said.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
1
举报
登录后可参与评论

暂无评论

